CoreAge Rx vs Pallas Health

The verdict for women

CoreAge Rx edges out Pallas Health on the Metabolic-Fit Score, 92 to 65 (A− vs C). Mothers who want a fixed monthly price, a real clinician rather than an intake quiz, and uninterrupted nationwide access to both semaglutide and tirzepatide while they work out the timing around pregnancy or weaning.

Pallas Health is still a genuine option — pallas Health carries both routes at once — compounded semaglutide at roughly $199 a month and tirzepatide at $299, alongside genuine FDA-approved Zepbound at $1,069, Ozempic at $1,299 and Wegovy and Mounjaro at $1,349, all cash-pay on one platform. The price is flat at every dose, answered directly in its own FAQ, and the clinician, dose adjustments, check-ins and messaging are inside that figure with no membership fee layered on. Two clinicians are named and both verify as active in the federal NPI registry, the LegitScript seal is genuine rather than a self-hosted image, and there is a real refund policy — full refund if a clinician declines you, a $5 processing fee on a qualifying cancellation. Two caveats matter for a household budget: billing lands every 12 weeks in $597 and $897 blocks rather than monthly, so the advertised per-month figures are Pallas's own averages, and the compounding pharmacy is never named. There is also no postpartum, breastfeeding or PCOS content on the site at all. Weigh the six women's-health factors below against your own priorities.